News and events

UiO:Life Science’s innovation programme SPARK Norway is designed to help academic innovators to advance promising research into value creating solutions. By applying a unique process model including mentoring, education, market exposure and global networks, SPARK Norway helps transforming good ideas into exceptional solutions.

On 9 and 10 June, NCMBM gathered at the Klækken Hotel in Hønefoss for two days of scientific talks, networking and community building.

The two-day retreat brought together around 80 participants to exchange knowledge, strengthen collaborations and connect with colleagues across the Centre.

A new study co-led by researchers at the Norwegian Centre for Molecular Biosciences and Medicine (NCMBM), and at the University of Helsinki has identified the protein SIT1 as a critical regulator of T cell activation and immune balance in humans. The findings, published in the Journal of Allergy and Clinical Immunology, provide important new insights into how the immune system is controlled and how disruptions in these mechanisms can contribute to immunodeficiency and cancer.

This study is the result of an international collaboration between researchers from Finland, Norway, Germany, and Austria.